Treatment outcome of tuberculosis patients under directly observed treatment short-course and factors affecting the outcome in tertiary care hospital


  • Parigna R. Trivedi Student, Gujarat Adani Institute of Medical Sciences, Bhuj, Gujarat, India
  • Tejas M. Khakhkhar Department of Pharmacology, Gujarat Adani Institute of Medical Sciences, Bhuj, Gujarat, India



DOTS, Factors, Treatment outcome, Tuberculosis


Background: Revised National Tuberculosis Control Programme (RNTCP) based on Directly Observed Treatment Short-course (DOTS) strategy has been made available in entire country by March 2006. Given high rate of unfavourable treatment outcomes reported in some provinces, there is a need to analyse outcomes and identify possible trends and associated risk factors that can help for improvement in RNTCP.

Methods: After getting Institutional Ethics Committee (IEC) approval, total of 76 cases diagnosed and treated for Tuberculosis (TB) under Category I of RNTCP were recruited from January to March 2017. All patients were followed up for six months from date of initiating the treatment. The data was obtained from TB treatment register, by patient visit and regular follow-up. The information collected include age and gender of patient, category of treatment, date of treatment initiation, initial sputum conversion, outcome of treatment and date of outcome.

Results: Out of total 76 patients, 64 (84.21%) were cured, 5 (6.57%) were lost to follow-up, 4 (5.26%) were failed to treat, 1 (1.32%) patient was died, 1 (1.32%) patient had completed treatment but status was unknown and 1 (1.32%) patient was not evaluated because of transfer. Overall treatment outcome of TB patients under DOTS was matching goal of RNTCP with cure rate of 84.21%.

Conclusions: Efforts by DOT providers, adequate patient education, motivating ones in need can bring positive outcomes. In this region, DOTS center is at good working condition in terms of functionality as well as ethically. Gender, age group, residence and initial culture colony did not significantly affect treatment outcome.


World Health Organization. Global Tuberculosis report. Available at:

Ramos JM, Reyes F, Facin R, Tesfamariam A. Surgical lymph node biopsies in a rural Ethiopian hospital: histopathologic diagnoses and clinical characteristics. Ethiopian Med J. 2008;46(2):173-8.

Chaulk CP, Kazandjian VA. Directly observed therapy for treatment completion of pulmonary tuberculosis: consensus statement of the public health tuberculosis guidelines panel. JAMA. 1998;279(12):943-8.

Kishore J. Revised national tuberculosis control program: DOTS strategy including DOTS plus. National health programs of India. 10th ed. New Delhi: Century publications, 2012:231-33.

Kanungo S, Khan Z, Ansari MA, Abedi AJ. Assessment of Directly Observed Treatment in Revised National Tuberculosis Control Programme: A Study from North India. J Nat Sci Biol Med. 2017;8(2):171-5.

Chennaveerappa PK, Siddharam SM, Halesha BR, Vittal BG, Jayashree N. Treatment outcome of tuberculosis patients registered at DOTS centre in a teaching hospital, South India. Int J Biol Med Res. 2011;2(2):487-9.

Ditah IC, Reacher M, Palmer C, Watson JM, Innes J, Kruijshaar ME, et al. Monitoring tuberculosis treatment outcome: analysis of national surveillance data from a clinical perspective. Thorax. 2008;63(5):440-6.

Vasudevan K, Jayakumar N, Gnanasekaran D. Smear conversion, treatment outcomes and the time of default in registered tuberculosis patients on RNTCP DOTS in Puducherry, Southern India. J Clin Diag Res. 2014 Oct;8(10):JC05.

Singh A, Bhardwaj A, Mukherjee AK, Arya R, Mithra P. current status of timing of treatment interruption and pattern of default among Tuberculosis patients on directly observed treatment. J Dr. NTR Univ Health Sci. 2013 Jul 1;2(3):177.

TB India 2013- RNTCP status report. Central TB Division, Directorate General of Health Services Ministry of Health and Family Welfare. Government of India. 2013.

Pardeshi GS. Time of default in tuberculosis patients on directly observed treatment. J Global Infect Dis. 2010 Sep;2(3):226.

Jha UM, Satyanarayana S, Dewan PK, Chadha S, Wares F, Sahu S, et al. Risk factors for treatment default among re-treatment tuberculosis patients in India, 2006. PLoS One. 2010 Jan 25;5(1):e8873.

Santha T, Garg R, Frieden T, Chandrasekaran V, Subramani R, Gopi P, et al. Risk factors associated with default, failure and death among tuberculosis patients treated in a DOTS programme in Tiruvallur District, South India, 2000. Int J Tuberculosis Lung Dis. 2002;6(9):780-8.

Gopi PG, Vasantha M, Muniyandi M, Balasubramanian R, Narayanan PR. Risk factors for non-adherence to directly observed treatment (DOT) in a rural tuberculosis unit, South India. Indian J Tuberculosis. 2007;54(2):66-70.

World health organization. 2014. Global Tuberculosis report. Available at:

Shunmugam M, Pratheeban J, Kumar PS, Ganesan M. A retrospective study on treatment outcomes of tuberculosis patients under RNTCP in tertiary care centre- Kanyakumari. J Evid Based Med Healthcare. 2017;4(2):59-63.

Gebrezgabiher G, Romha G, Ejeta E, Asebe G, Zemene E, Ameni G. Treatment Outcome of Tuberculosis Patients under Directly Observed Treatment Short Course and Factors Affecting Outcome in Southern Ethiopia: A Five-Year Retrospective Study. PLoS One 2016;11(2):e0150560.

Sisay S, Mengistu B, Erku W, Woldeyohannes D. Directly Observed Treatment Short-course (DOTS) for tuberculosis control program in Gambella Regional State, Ethiopia: ten years experience. BMC Res Notes. 2014 Dec;7(1):44.

Tessema B, Muche A, Bekele A, Reissig D, Emmrich F, Sack U. Treatment outcome of tuberculosis patients at Gondar University Teaching Hospital, Northwest Ethiopia. A five-year retrospective study. BMC Public Health. 2009 Dec;9(1):371.

Begum V, De Colombani P, Das Gupta S, Salim Md A H, Hussain H, Pietroni M, et al. Tuberculosis and patient gender in Bangladesh: sex differences in diagnosis and treatment outcome. Int J Tuberculosis Lung Dis. 2001 Jul 1;5(7):604-10.

Caylà JA, Caminero JA, Rey R, Lara N, Valles X, Galdós-Tangüis H. Current status of treatment completion and fatality among tuberculosis patients in Spain. Int J Tuberculosis Lung Dis. 2004 Apr 1;8(4):458-64.

Melese A, Zeleke B, Ewnete B. Treatment outcome and associated factors among tuberculosis patients in Debre Tabor, Northwestern Ethiopia: a retrospective study. Tuberculosis Res Treatment. 2016;2016.

Ambadekar NN, Zodpey SP, Soni RN, Lanjewar SP. Treatment outcome and its attributes in TB-HIV co-infected patients registered under Revised National TB Control Program: a retrospective cohort analysis. Public Health. 2015;129(6):783-9.

Jain K, Desai M, Solanki R, Dikshit RK. Treatment outcome of standardized regimen in patients with multidrug resistant tuberculosis. J Pharmacol Pharmacotherapeut. 2014;5(2):145.

Prasad R, Suryakant RG, Singhal S, Dawar R, Agarwal GG. A case-control study of tobacco smoking and tuberculosis in India. Ann Thoracic Med. 2009;4(4):208.

Prajapati K, Mishra V, Desai M, Solanki R, Naik P. Treatment outcome of patients having extensively drug-resistant tuberculosis in Gujarat, India. Int J Mycobacteriol. 2017 Jul 1;6(3):289.

Nwokeukwu HI, Awujo DN, Emma-Ukeagbu U. Association of sputum conversion and outcome with initial smear grading among new smear positive Tuberculosis patients in a Tertiary Health Facility, South East Zone, Nigeria. J Dental Med Sci. 2013;4(6):2279-0853.




How to Cite

Trivedi, P. R., & Khakhkhar, T. M. (2019). Treatment outcome of tuberculosis patients under directly observed treatment short-course and factors affecting the outcome in tertiary care hospital. International Journal of Basic & Clinical Pharmacology, 8(5), 981–986.



Original Research Articles